EISENBERG OR (Chief Financial Officer) purchased 19.9% of their position (250K shares) of NEUROSENSE THERAPEUTICS LTD. on the open market
Open‑market purchase worth $200.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/17/2026ACC: 0001213900-26-069662
Officer· Chief Financial Officer
Since Mar 2026
+250K
Net shares
Net buyer
$200.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
250K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+250K
Price / share
$0.80
Trade value
$200K
% of position
19.9%
6/16/2026
1.25M→1.50M
Total
Net shares
+250K
Net value
$200K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/16/2026 | P · Purchase | +250K | $0.80 | $200K | 19.9% | 1.25M | 1.50M |
| Total | +250K | $200K | ||||||
Derivative Transactions0
No derivative transactions reported